ICOS and autoimmune disease: Thereby, ICOS-signaling equips ICOS+-Tregs and, presumably, ICOS+-Tresps with increased proliferation and survival abilities and therefore identifies both ICOS+-Tregs/Tresps as outstanding T-helper cell populations that may potentially affect the regulation of immune responses during autoimmune diseases [21,22].